Clinical Scorecard: Gender Variations in Cardiovascular–Kidney–Metabolic Risk Factors Linked to Degenerative Valvular Heart Disease
At a Glance
Category
Detail
Condition
Degenerative valvular heart disease (VHD)
Key Mechanisms
Interplay of cardiovascular–kidney–metabolic (CKM) risk factors including hypertension, diabetes, obesity, hypertriglyceridaemia, and chronic kidney disease contributing to VHD development and progression
Target Population
Middle-aged adults (40-69 years) free of VHD or heart failure at baseline
Care Setting
Primary prevention and early-stage multidisciplinary disease management
Key Highlights
Hypertension is the largest attributable risk factor for incident VHD in both sexes.
Women have higher risks of specific VHD subtypes with certain CKM risk factors: aortic stenosis with obesity, aortic regurgitation with chronic kidney disease, and mitral regurgitation with hypertension or hypertriglyceridaemia.
Tailoring CKM risk factor prioritization by gender may enhance prevention strategies for degenerative VHD.
Guideline-Based Recommendations
Diagnosis
Assess presence of CKM risk factors (hypertension, diabetes, obesity, hypertriglyceridaemia, CKD) in patients at risk for VHD.
Consider sex-specific risk profiles when evaluating risk for VHD subtypes.
Management
Implement early multidisciplinary interventions targeting CKM risk factors to prevent or delay VHD onset.
Manage hypertension aggressively as a key modifiable risk factor for VHD.
Customize prevention strategies based on patient sex, emphasizing obesity management in women for aortic stenosis and CKD management for aortic regurgitation.
Monitoring & Follow-up
Regularly monitor CKM risk factors and cardiac valve function in at-risk populations.
Track sex-specific progression patterns of VHD to adjust management plans accordingly.
Risks
Delayed or absent intervention in CKM risk factors increases risk of degenerative VHD and related morbidity.
Women with obesity, CKD, hypertension, or hypertriglyceridaemia have elevated risk for specific VHD subtypes.
Patient & Prescribing Data
Middle-aged adults without baseline VHD or heart failure, stratified by sex
Hypertension management is critical across sexes; however, female patients may benefit from targeted interventions addressing obesity, CKD, and lipid abnormalities to reduce VHD risk.
Clinical Best Practices
Screen for and manage multiple CKM risk factors early to prevent degenerative VHD.
Incorporate sex-specific risk assessment in clinical evaluation and prevention planning.
Promote lifestyle modifications and pharmacologic treatments tailored to individual CKM profiles.
Recognize that current treatment options for advanced VHD are limited, underscoring the importance of early prevention.
